Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Apr 29, 2026 · Quart Barry D sold 13.10K shares at $50.10/share ($656.3K); exercised options for 13.10K shares

Quart Barry D sold 13.10K shares at $50.10/share ($656.3K); exercised options for 13.10K shares

xslF345X06/form4-04292026_080403.xml

xslF345X06/form4-04292026_080403.xmlSEC.gov

Graphics and non-inline formats (not embedded below).